{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Singh B"],"funding":["NIMH NIH HHS","J. Willard and Alice S. Marriott Foundation","National Institute of Mental Health","Australian Government","NIHR Maudsley Biomedical Research Centre"],"pagination":["22-32"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10794603"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["26(1)"],"pubmed_abstract":["<h4>Objectives</h4>To understand treatment practices for bipolar disorders (BD), this study leveraged the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic treatment patterns in multiple cohorts of well-characterized individuals with BD in North America, Europe, and Australia.<h4>Methods</h4>Data on pharmacotherapy, demographics, diagnostic subtypes, and comorbidities were provided from each participating cohort. Individual site and regional pooled proportional meta-analyses with generalized linear mixed methods were conducted to identify prescription patterns.<h4>Results</h4>This study included 10,351 individuals from North America (n = 3985), Europe (n = 3822), and Australia (n = 2544). Overall, participants were predominantly female (60%) with BD-I (60%; vs."],"journal":["Bipolar disorders"],"pubmed_title":["Patterns of pharmacotherapy for bipolar disorder: A GBC survey."],"pmcid":["PMC10794603"],"funding_grant_id":["R01MH100125","R01 MH100125"],"pubmed_authors":["Millett CE","Pham D","Godin O","Dubertret C","Samalin L","Yocum AK","Haffen E","Peters AT","Vieta E","Strawbridge R","Coombes BJ","Young AH","Olie E","Burdick KE","Tso IF","Andreassen OA","Andreazza AC","Zandi PP","Biernacka JM","Aubin V","Nierenberg AA","Fullerton JM","Fico G","Leboyer M","Verdolini N","Schwan R","Keramatian K","Frye MA","Yatham LN","Singh B","Sperry SH","Gard S","Berk M","Mitchell PB","Belzeaux R","Etain B","Williams LJ","FACE-BD Collaborators, The Global Bipolar Cohort Collaborative","Ashton MM","Passerieux C","Overs BJ","Polosan M","McInnis MG","Roberts G"],"additional_accession":[]},"is_claimable":false,"name":"Patterns of pharmacotherapy for bipolar disorder: A GBC survey.","description":"<h4>Objectives</h4>To understand treatment practices for bipolar disorders (BD), this study leveraged the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic treatment patterns in multiple cohorts of well-characterized individuals with BD in North America, Europe, and Australia.<h4>Methods</h4>Data on pharmacotherapy, demographics, diagnostic subtypes, and comorbidities were provided from each participating cohort. Individual site and regional pooled proportional meta-analyses with generalized linear mixed methods were conducted to identify prescription patterns.<h4>Results</h4>This study included 10,351 individuals from North America (n = 3985), Europe (n = 3822), and Australia (n = 2544). Overall, participants were predominantly female (60%) with BD-I (60%; vs.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-21T23:48:56.559Z","creation":"2025-04-05T19:19:50.502Z"},"accession":"S-EPMC10794603","cross_references":{"pubmed":["37463846"],"doi":["10.1111/bdi.13366"]}}